Nano-X Imaging awards marketing chief a stock grant
The EVP's RSU installments run from February 2027 through August 2028 and each is subject to continued employment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Nano-X Imaging Ltd. (NNOX) EVP & Chief Marketing Officer Cohen Tamar Aharon was granted 28,283 restricted share units on October 11, 2026. They vest in four equal semi-annual installments of 25% each on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject to continuous employment on each vesting date. Separate informational holdings list direct options over 33,000, 17,000, 8,000 and 55,000 ordinary shares, with exercise prices of $49.68, $17.63, $17.63 and $11.52, respectively.
Insider Trade Summary
Grant/Award: 28,283 shares
Grant/Award
7 txns
Insider
Aharon Cohen Tamar
Role
EVP & Chief Marketing Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares F1, F2 | 28,283 | $0.00 | $0.00 |
| holding | Stock Option (right to buy ordinary shares) F3, F5 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F6 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F7 | -- | -- | -- |
| holding | Stock Option (right to buy ordinary shares) F3, F8 | -- | -- | -- |
| holding | Ordinary Shares F3 | -- | -- | -- |
| holding | Ordinary Shares F3, F4 | -- | -- | -- |
Holdings After Transaction:
Ordinary Shares — 87,757 shares (Direct);
Stock Option (right to buy ordinary shares) — 113,000 contracts (Direct)
Footnotes (8)
- F1. The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.
- F2. The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028), all underlying shares will be issued to the Reporting Person.
- F3. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% on the 24-month anniversary of the grant date (February 5, 2028).
- F5. The options reported in this row were granted to the Reporting Person by the Issuer on January 18, 2021 and are fully vested and exercisable as of the date of this report.
- F6. The options reported in this row were granted to the Reporting Person by the Issuer on March 28, 2022 and are fully vested and exercisable as of the date of this report.
- F7. The options reported in this row were granted to the Reporting Person by the Issuer on May 16, 2022 and are fully vested and exercisable as of the date of this report.
- F8. The options reported in this row were granted to the Reporting Person by the Issuer on May 23, 2023 and vest and become exercisable in 16 equal quarterly installments of 6.25% each on each three-month anniversary of the grant date, such that all options reported in this row will be exercisable by the four-year anniversary of the grant date (May 23, 2027).
Key Figures
Restricted share units granted: 28,283 RSUs
RSU vesting installments: Four installments of 25% each
Option underlying shares and exercise price: 33,000 ordinary shares; $49.68
+3 more
6 metrics
Restricted share units granted
28,283 RSUs
Granted October 11, 2026
RSU vesting installments
Four installments of 25% each
February 13, 2027; August 13, 2027; February 13, 2028; August 13, 2028
Option underlying shares and exercise price
33,000 ordinary shares; $49.68
Direct option holding; expires January 18, 2031
Option underlying shares and exercise price
17,000 ordinary shares; $17.63
Direct option holding; expires March 28, 2032
Option underlying shares and exercise price
8,000 ordinary shares; $17.63
Direct option holding; expires May 16, 2032
Option underlying shares and exercise price
55,000 ordinary shares; $11.52
Direct option holding; expires May 23, 2033
Key Terms
restricted share units, vesting commencement date, fully vested and exercisable
3 terms
vesting commencement date technical
"vesting commencement date of August 13, 2026"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
fully vested and exercisable financial
"fully vested and exercisable as of the date of this report"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many RSUs did NNOX's EVP and Chief Marketing Officer receive?
Cohen Tamar Aharon was granted 28,283 RSUs on October 11, 2026. They vest in four equal semi-annual installments of 25% each, on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028, subject to continuous employment on each vesting date.
What option holdings did NNOX's EVP and Chief Marketing Officer report?
The listed direct options cover 33,000 ordinary shares at a $49.68 exercise price, expiring January 18, 2031; 17,000 at $17.63, expiring March 28, 2032; 8,000 at $17.63, expiring May 16, 2032; and 55,000 at $11.52, expiring May 23, 2033. The first three grants were fully vested and exercisable; the 55,000-option grant vests quarterly and will be exercisable by May 23, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
